Axis-Shield Ltd Stock

Stocks

Delayed London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

20-07-29	Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	PU
20-07-29	Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	PU
20-07-29	Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	PU
20-07-29	Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	PU
20-07-29	Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	PU

Manager	Title	Age	Since
Erling M. H. Sundrehagen CTO	Chief Tech/Sci/R&D Officer	74	1983-12-31
Atle Schjøtt PRN	Corporate Officer/Principal	-	2010-09-19
Guido Schilling PRN	Corporate Officer/Principal	-	2010-09-19

Director	Title	Age	Since
Erling M. H. Sundrehagen BRD	Director/Board Member	74	1983-12-31
Benjamin Edward Oosterbaan BRD	Director/Board Member	63	-
Brian Yoor BRD	Director/Board Member	56	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXIS-SHIELD LTD	-.--%	-.--%	-	-	0
GUARDANT HEALTH, INC.	-3.07%	+3.59%	+193.95%	+565.91%	23.33B
10X GENOMICS, INC.	+3.26%	+12.82%	+506.60%	+88.74%	10.31B
BIOMÉRIEUX	+0.55%	-0.14%	-36.28%	-20.06%	9.76B
CARIS LIFE SCIENCES, INC.	+2.23%	+17.66%	-5.92%	-	8.66B
LANTHEUS HOLDINGS, INC.	-0.27%	-0.04%	+98.93%	+66.38%	6.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.22%	+1.05%	-27.93%	-21.41%	5.76B
DIASORIN S.P.A.	-0.74%	+4.34%	-1.00%	-10.56%	4.43B
ANDON HEALTH CO., LTD.	+2.67%	+7.74%	+65.15%	+70.58%	4B
AUTOBIO DIAGNOSTICS CO., LTD.	+1.09%	+2.49%	-19.18%	-29.97%	2.77B
Average	+0.59%	+5.07%	+86.03%	+88.70%	7.56B
Weighted average by Cap.	-0.05%	+5.84%	+132.75%	+215.06%